Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
D000208:Acute Disease; D000328:Adult; D001921:Brain / Q000378:metabolism; D002908:Chronic Disease; D003711:Demyelinating Diseases / Q000134:cerebrospinal fluid; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008297:Male; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000627:therapeutic use
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid; D006719:Homovanillic Acid